Search Within

Mark Kris

Formats
  1. Journal Article (480)
  2. Meeting Abstract (356)
  3. Conference Paper (16)
  4. Book Section (9)
  5. Review (6)
  6. Guidelines (2)
  7. Editorial (1)
  8. Miscellaneous (1)
  9. Research Letter (1)
Groups
  1. Department of Medicine (872)
  2. Solid Tumor Oncology Division (872)
  3. Thoracic Oncology (872)
  4. Department of Pathology and Laboratory Medicine (319)
  5. GSK Faculty (292)
  6. Human Oncology and Pathogenesis Program (225)

More Groups

People
  1. Gregory Riely (222)
  2. Marc Ladanyi (190)
  3. Vincent Miller (172)
  4. Valerie Rusch (130)
  5. Maria Arcila (123)
  6. Jamie Chaft (107)

More People

Years
  1. 2025 (7)
  2. 2024 (18)
  3. 2023 (27)
  4. 2022 (21)
  5. 2021 (21)
  6. 2020 (25)

More Years

Publications
  1. Journal of Clinical Oncology (235)
  2. Journal of Thoracic Oncology (131)
  3. Clinical Cancer Research (65)
  4. Cancer (33)
  5. Lung Cancer (31)
  6. Annals of Oncology (25)

More Publications

Publishers
  1. American Society of Clinical Oncology (253)
  2. Elsevier Inc. (179)
  3. American Association for Cancer Research (105)
  4. Oxford University Press (48)
  5. Wiley Blackwell (36)
  6. Elsevier Ireland Ltd. (30)

More Publishers

Results (872)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 2 trial of bortezomib in KRAS G12D mutant lung cancers
    Meeting Abstract

    Riely, G. J.; Litvak, A.; Rekhtman, N.; Pietanza, M. C.; Chaft, J. E.; Woo, K.; Paik, P.; Miller, V.; Kris, M. G.; Rodriguez, K.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Diagnostic molecular testing in multiple lung cancers
    Meeting Abstract

    Naidoo, J.; Woo, K.; Sima, C. S.; Travis, W. D.; Arcila, M. E.; Finley, D. J.; Rusch, V.; Jones, D. R.; Kris, M. G.; Zauderer, M. G.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • A phase 1 study of erlotinib and ruxolitinib in patients with EGFR-mutant lung cancers and acquired resistance to erlotinib therapy
    Meeting Abstract

    Yu, H.; Perez, L. A.; Sima, C. S.; Li, B. T.; Smith-Marrone, S.; Iqbal, A.; Paik, P.; Drilon, A.; Kris, M. G.; Bromberg, J.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Clinically adoption of MSK-IMPACT, a hybridization capture-based next generation sequencing assay, for the assessment of lung adenocarcinomas
    Meeting Abstract

    Arcila, M. E.; Zehir, A.; Yu, H.; Drilon, A.; Li, B. T.; Riely, G. J.; Rekhtman, N.; Lin, O.; Hyman, D.; Berger, M.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Comprehensive mutation analysis of never-smokers with small cell lung cancer (SCLC)
    Meeting Abstract

    Pietanza, M. C.; Won, H.; Krug, L. M.; Varghese, A. M.; Riely, G. J.; Rekhtman, N.; Wang, L.; Travis, W. D.; Zakowski, M.; Ladanyi, M.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Multiple lung cancers: Is their survival better or worse then other lung cancers?
    Meeting Abstract

    Naidoo, J.; Woo, K.; Sima, C. S.; Travis, W. D.; Arcila, M.; Finley, D. J.; Rusch, V. W.; Jones, D. R.; Kris, M. G.; Zauderer, M.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Oncogenic drivers including RET and ROS1 plus PTEN loss and MET by IHC in patients with lung adenocarcinomas: Lung Cancer Mutation Consortium 2.0
    Meeting Abstract

    Johnson, B. E.; Kris, M. G.; Wistuba, I. I.; Berry, L.; Socinski, M. A.; Ramalingam, S. S.; Glisson, B.; Otterson, G.; Schiller, J.; Cetnar, J.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Clinical outcomes with pemetrexed-based systemic therapy in RET-rearranged lung cancers
    Meeting Abstract

    Drilon, A.; Bergagnini, I.; Delasos, L.; Sima, C. S.; Smith, R.; Somwar, R.; Riely, G. J.; Kris, M. G.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Ado-trastuzumab emtansine for HER2 amplified or HER2 overexpressed cancers: A phase II "basket" trial
    Meeting Abstract

    Li, B. T.; Zauderer, M.; Chaft, J.; Drilon, A.; Eng, J.; Sima, C.; Makker, V.; Iyer, G.; Janjigian, Y.; Hyman, D.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • HER2 insertion YVMA mutant lung cancer: Long natural history and response to afatinib
    Journal Article

    Li, B. T.; Lee, A.; O'toole, S.; Cooper, W.; Yu, B.; Chaft, J. E.; Arcila, M. E.; Kris, M. G.; Pavlakis, N.
    Lung Cancer (2015)

    Fulltext@MSK | Save